Legacy Advisors »

Regeneron Pharmaceuticals shares owned by Legacy Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Legacy Advisors from 13F filings

Historical chart of Legacy Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Legacy Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Legacy Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $200k 208 962.49
2017-09-30 $8.0k 20 400.00

More positions owned by Legacy Advisors

MasTec (MTZ)
Vertex Cl A (VERX)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Rus Mid Cap Etf (IWR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)
Meta Platforms Cl A (META)
Amazon (AMZN)
Select Sector Spdr Tr Technology (XLK)
Bentley Sys Com Cl B (BSY)
Alphabet Cap Stk Cl A (GOOGL)
Uber Technologies (UBER)

View all positions for Legacy Advisors

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals